This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Avon (AVP) Q3 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Avon's (AVP) focus on pricing and productivity initiatives drives adjusted operating margin. Also, the company is progressing well with its "Open Up Avon" strategy.
Things You Should Note Ahead of Sysco's (SYY) Q1 Earnings
by Zacks Equity Research
Sysco Corporation (SYY) is likely to have gained from favorable local case volumes in the U.S. Foodservice unit in the fiscal first quarter.
Church & Dwight (CHD) Q3 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Church & Dwight's (CHD) Q3 earnings and sales improve on gains from most product categories.
Estee Lauder (EL) Stock Down Despite Q1 Earnings & Sales Beat
by Zacks Equity Research
The Estee Lauder's (EL) first-quarter fiscal 2020 results reflect strength in the Skin Care category, Estee Lauder brand, and travel retail and online channels.
What Makes Inter Parfums (IPAR) a New Buy Stock
by Zacks Equity Research
Inter Parfums (IPAR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Timing the Market, Is it Possible? - October 30, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Inter Parfums (IPAR) Earnings Expected to Grow: What to Know Ahead of Q3 Release
by Zacks Equity Research
Inter Parfums (IPAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inter Parfums (IPAR) Gains on Solid Units Despite Cost Woes
by Zacks Equity Research
Solid product portfolio and strong European operations unit are likely to help boost Inter Parfums' (IPAR) growth. However, rising expenses is concerning.
NUS vs. IPAR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NUS vs. IPAR: Which Stock Is the Better Value Option?
The Keys to Successfully Timing the Markets - October 01, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Estee Lauder (EL) Up 44% in a Year: Factors Driving the Stock
by Zacks Equity Research
Estee Lauder (EL) focuses on enhancing travel retail business. Also, robust online network bodes well.
Timing the Market, Is it Possible? - September 10, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Nu Skin Down 12% in 3 Months, Mainland China is a Concern
by Zacks Equity Research
Nu Skin (NUS) is battling headwinds in Mainland China, stemming from the government's campaign to scrutinize offerings of direct selling and health products industries.
Clorox (CLX) Declines Post Soft FY20 View: Is This Temporary?
by Zacks Equity Research
Headwinds in the Charcoal, and Bags and Wraps businesses are hurting Clorox's (CLX) sales performance. But its robust fundamentals, initiatives and earnings trend indicate solid long-term prospects.
Helen of Troy Hits 52-Week High: Here Are the Factors at Play
by Zacks Equity Research
Helen of Troy (HELE) is benefiting from strong Leadership Brands, robust online sales and core business advancements. The company is also on track with its transformation plan.
Coty (COTY) Q4 Earnings in Line, Revenues Miss Estimate
by Zacks Equity Research
Coty's (COTY) Q4 results depicts persistent softness in the Consumer Beauty segment, due to weakness in Younique. However, growth in the Luxury unit is an upside.
Cosmetics Industry Outlook Looks Radiant on Solid Sales Channels
by Vrishali Bagree
Cosmetics industry players are set to gain on strong travel retail and digital sales. Also, focus on innovation bodes well.
Will McCormick Keep Dazzling on Strong Brands & Saving Plans?
by Zacks Equity Research
McCormick (MKC) is on track with the CCI program to boost savings. Also, it focuses on new product development to augment market reach.
Estee Lauder (EL) Q4 Earnings & Sales Top Estimates, Stock Up
by Zacks Equity Research
Estee Lauder's (EL) top and bottom lines improve year over year and surpass estimates in Q4. The company continues to gain from strength in most categories.
Zacks.com featured highlights include: Inter Parfums, Glu Mobile, Centene, Fortinet and Remark Media
by Zacks Equity Research
Zacks.com featured highlights include: Inter Parfums, Glu Mobile, Centene, Fortinet and Remark Media
Bet on Rising P/E Stocks to Enjoy Solid Gains
by Sanghamitra Saha
Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.
Inter Parfums (IPAR) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Inter Parfums (IPAR) delivered earnings and revenue surprises of 2.63% and 0.03%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Yes, You Can Time the Market. Find out How - August 05, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Avon (AVP) Q2 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
Avon's (AVP) sales and earnings in second-quarter 2019 gain from progress on the Open Up Avon strategy. Its focus on pricing and productivity initiatives drives adjusted operating margin growth.
Can Cost and Tariff Woes Mar Clorox's (CLX) Earnings in Q4?
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2019 results are likely to bear impacts of higher commodity costs, adverse currency, increased manufacturing and logistics expenses, and tariffs.